Adial Pharmaceuticals日前通过美国证券交易委员会(SEC)提交的文件透露,公司预计将在2026年年度股东大会之后,终止首席财务官Vinay Shah的职务。
Adial Pharmaceuticals日前通过美国证券交易委员会(SEC)提交的文件透露,公司预计将在2026年年度股东大会之后,终止首席财务官Vinay Shah的职务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.